Daiwa Securities Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-102
| Closed | – | – | 1321 |
|
|
2022
Q3 | $0 | Hold |
102
| – | – | ﹤0.01% | 1341 |
|
|
2022
Q2 | $0 | Hold |
102
| – | – | ﹤0.01% | 1361 |
|
|
2022
Q1 | $0 | Hold |
102
| – | – | ﹤0.01% | 1376 |
|
|
2021
Q4 | $0 | Hold |
102
| – | – | ﹤0.01% | 1395 |
|
|
2021
Q3 | $1K | Hold |
102
| – | – | ﹤0.01% | 1261 |
|
|
2021
Q2 | $1K | Hold |
102
| – | – | ﹤0.01% | 1181 |
|
|
2021
Q1 | $1K | Hold |
102
| – | – | ﹤0.01% | 1190 |
|
|
2020
Q4 | $1K | Sell |
102
-183
| -64% | -$1.79K | ﹤0.01% | 1167 |
|
|
2020
Q3 | $2K | Hold |
285
| – | – | ﹤0.01% | 1129 |
|
|
2020
Q2 | $2K | Hold |
285
| – | – | ﹤0.01% | 1141 |
|
|
2020
Q1 | $2K | Hold |
285
| – | – | ﹤0.01% | 1145 |
|
|
2019
Q4 | $2K | Hold |
285
| – | – | ﹤0.01% | 1147 |
|
|
2019
Q3 | $2K | Hold |
285
| – | – | ﹤0.01% | 1113 |
|
|
2019
Q2 | $3K | Buy |
285
+73
| +34% | +$768 | ﹤0.01% | 1109 |
|
|
2019
Q1 | $2K | Hold |
212
| – | – | ﹤0.01% | 1115 |
|
|
2018
Q4 | $3K | Hold |
212
| – | – | ﹤0.01% | 1077 |
|
|
2018
Q3 | $4K | Hold |
212
| – | – | ﹤0.01% | 1075 |
|
|
2018
Q2 | $5K | Hold |
212
| – | – | ﹤0.01% | 1082 |
|
|
2018
Q1 | $6K | Buy |
+212
| New | +$6K | ﹤0.01% | 1051 |
|